IESE (España)
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
GAM
Oleaga M.; Campa, Jose ManuelCase F-817-EFinanceAt the end of the 2005 fiscal year and given its position as market leader and its profitable growth over the previous years, GAM pondered on the following changes: getting listed on the Stock Exchange, selling the company to an international group or even to another larger capital risk company who would like to broaden their business with a second phase of company acquisitions.Starting at €8.20
-
Grupo Santander: medidas de blindaje
Oleaga M.; Campa, Jose ManuelCase F-784Corporate Governance, FinanceA partir de las decisiones que se analizan en el Grupo Santander, se estudian las reformas de las prácticas de gobierno corporativo dentro de la empresa, en especial la relativa a la eliminación de las medidas de blindaje existentes en los estatutos.Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
GAM
Oleaga M.; Campa, Jose ManuelCase F-817FinanceA cierre del ejercicio 2005, y dada su posición de liderazgo en el mercado y su rentable crecimiento en los últimos años, GAM se plantea las siguientes alternativas: una salida a bolsa, la venta de la empresa a grupos internacionales o, incluso, la venta de la empresa a otra sociedad de capital riesgo de mayor envergadura que quisiera ampliar el negocio con una segunda fase de adquisiciones de empresas.Starting at €8.20